Bioactivation of an anorganic bone matrix by P-15 peptide for the promotion of early bone formation
Neuropharmacology 77:100119 lvarez-Prez B, Homs J, Bosch-Mola M, Puig T, Reina F, Verd E, Boadas-Vaello P (2016) Epigallocatechin-3-gallate treatment reduces thermal hyperalgesia after spinal cord injury by down-regulating RhoA expression in mice
glucose homeostasis, evaluated using fasting plasma glucose, oral glucose tolerance tests (OGTTs), insulin levels, and homeostatic model assessment of insulin resistance (HOMA IR) indices
BPC-157 (Pentadecapeptide) Side effects Pain at the injection site, inflammation, fatigue, dizziness